Curr Pharm Des 24:19721989 ebei B, Nikoli V, Sikiri P, Seiwerth S, oa T, Patrlj L, Grabarevi , Ruman R, Petek M, Konjevoda P (1999) Osteogenic effect of a gastric pentadecapeptide, BPC 157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation
How it helps disc herniation specifically: Upregulates tendon-related growth factors BPC-157 activates the Egr-1 transcription factor, which drives collagen synthesis in fibrous tissue including the annulus fibrosus Promotes angiogenesis increases VEGF expression, improving blood supply to the avascular disc environment Neuroprotective effects multiple rodent studies show BPC-157 accelerates peripheral nerve regeneration and protects against nerve compression injury Systemic anti-inflammatory suppresses pro-inflammatory cytokine cascades without the immunosuppressive side effects of steroids Protocol: Dose: 250500mcg/day subcutaneous injection Injection site: Lower abdomen or closest accessible subQ site to the injury (though systemic distribution means proximity matters less than for localized joint issues) Duration: 68 weeks loading phase, reassess at week 8 Most people notice reduced nerve pain and improved mobility within 24 weeks
While microdosing programs are not intended for significant weight loss, program participants may experience reduced appetite and cravings, leading to gradual, sustained weight management
What Is GLOW Peptide
